After a 35% fall in ten trading sessions, Akums Drugs shares hit an upper circuit

Share it

Shares of Akums Drugs had declined 35% in the last 10 trading sessions before Tuesday’s upper circuit.

Leave a Comment

Your email address will not be published. Required fields are marked *